Amanda Morgan
Corporate Officer/Principal chez LANTHEUS HOLDINGS, INC.
Fortune : 2 M $ au 30/04/2024
Profil
Amanda Morgan is currently the Chief Commercial Officer at Lantheus Holdings, Inc. She previously worked as the Vice President-Sales & Market Access at ACADIA Pharmaceuticals, Inc. from 2017 to 2019.
Before that, she was the Head-Patient Services at Baxalta, Inc. from 2012 to 2016.
Amanda also served as the Vice President-U.S.
Sales at Baxter & Co. from 2008 to 2012.
She obtained her undergraduate degree from the University of Iowa in 2000.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LANTHEUS HOLDINGS INC
0,04% | 25/03/2024 | 25 411 ( 0,04% ) | 2 M $ | 30/04/2024 |
Postes actifs de Amanda Morgan
| Sociétés | Poste | Début |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Corporate Officer/Principal | 29/11/2022 |
Anciens postes connus de Amanda Morgan
| Sociétés | Poste | Fin |
|---|---|---|
| BAXALTA INC | Corporate Officer/Principal | 01/03/2016 |
Baxter & Co.
 Baxter & Co. Other Consumer ServicesConsumer Services Baxter & Co. provides beauty care and hairdressing services. The private company is based in Franklin, TN. | Sales & Marketing | 01/09/2012 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Formation de Amanda Morgan
| University of Iowa | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Baxter & Co.
Baxter & Co. Other Consumer ServicesConsumer Services Baxter & Co. provides beauty care and hairdressing services. The private company is based in Franklin, TN. | Consumer Services |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
